Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Bevacizumab

Reversible posterior leukoencephalopathy syndrome: case report

    This is a preview of subscription content, log in to check access.

    REFERENCE

    1. 1.

      Lou E, Turner S, Sumrall A, Reardon DA, Desjardins A, Peters KB, Sampson JH, Friedman HS, Vredenburgh JJ.Bevacizumab-induced reversible posterior leukoencephalopathy syndrome and successful retreatment in a patient with glioblastoma. Journal of Clinical Oncology 29: e739-e742, No. 28, Oct 2011. Available from: URL: http://dx.doi.org/10.1200/jco.2011.36.1865 - USA

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Bevacizumab. React. Wkly. 1381, 7 (2011). https://doi.org/10.2165/00128415-201113810-00020

    Download citation

    Keywords

    • Bevacizumab
    • Imatinib
    • Nifedipine
    • Etoposide
    • Temozolomide